2005 AMD ARTICLES

Anderson, A., et al., "Characteristics of the Normative Database for the Humphrey Matrix Perimeter," Investigative Ophthalmology & Visual Science 46 (2005) p.1540-1548

Arias, L. et al., "Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration," British Journal of Ophthalmology 89:3 (2005) p.312-315

Augustin, A., et al., "Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration," Graefe's Archive for Clinical and Experimental Ophthalmology 243:1 (2005) p.9-12

Azab, M. et al., "Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-Related Macular Degeneration: 2-Year Results of a Randomized Clinical Trial," Archives of Ophthalmology, 123:4 (2005) p.448-457

Beaumont, P., and Kang, H., "Balancing the risks and benefits in AMD," Clinical and Experimental Ophthalmology 33:1 (2005) p.108-110

Beldem, H., "Eye of the beholder: New and emerging therapies for macular degeneration," Drug topics. 149:3 (2005) p.34-37

Berdeaux, G., et al., "Vision-related quality of life in patients suffering from age-related macular degeneration," American Journal of Ophthalmology 139:2 (2005) p.271-279

Bora, P., et al., "Role of Complement and Complement Membrane Attack Complex in Laser-Induced Choroidal Neovascularization," Journal of Immunology 174:1 (2005) p.491-497

Brody, B., et al., "Self-management of Age-related Macular Degeneration at the 6-Month Follow-up: A Randomized Controlled Trial," Archives of Ophthalmology 123:1 (2005) p.46-53

Brody, B., et al., "Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trial," British Journal of Ophthalmology 89:1 (2005) p.46-53

Cahill, M., et al., "Quality of life after macular translocation with 360° peripheral retinectomy for age-related macular degeneration," Ophthalmology 112:1 (2005) p.144-151

Cahill, M., et al., "Vision-related quality of life in patients with bilateral severe age-related macular degeneration," Ophthalmology 112:1 (2005) p.152-158

Cheng, C. et al., "Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial," The British Journal of Nutrition 93:1 (2005) p.123-130

Cheong, A., et al., "Short-Term In-Office Practice Improves Reading Performance with Stand Magnifiers for People with AMD," Optometry and Vision Science 82:2 (2005) p.114-127

Chew, E., and Clemons, T., "Vitamin E and the Age-Related Eye Disease Study Supplementation for Age-Related Macular Degeneration," Archives of Ophthalmology 123:3 (2005) p.395-396

Chong N., et al., "Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration," The American Journal of Pathology 166:1 (2005) p.241-251

Deckert, A., et al., "Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO)," BMC Ophthalmology 5:8 (2005) http://www.biomedcentral.com/1471-2415/5/8/abstract

Ding, K., et al., "Retinal Disease in Mice Lacking Hypoxia-Inducible Transcription Factor-2," Investigative Ophthalmology & Visual Science 46 (2005) p.1010-1016

Esfandiary, H., et al., "Association study of detoxification genes in age related macular degeneration," British Journal of Ophthalmology 89:4 (2004) p.470-474

Ethen. C., et al., "Declines in Arrestin and Rhodopsin in the Macula with Progression of Age-Related Macular Degeneration," Investigative Ophthalmology & Visual Science 46 (2005) p.769-775

Fernandez-Robredo, P., et al., "Vitamins C and E Reduce Retinal Oxidative Stress and Nitric Oxide Metabolites and Prevent Ultrastructural Alterations in Porcine Hypercholesterolemia," Investigative Ophthalmology & Visual Science 46 (2005) p.1140-1146

Fine. S.L., "Age-related macular degeneration 1969–2004: A 35-year personal perspective," American Journal of Ophthalmology 139:4 (2005) p.405-420.

Fraser-Bell, S., et al., "Sociodemographic factors and age-related macular degeneration in Latinos: The Los Angeles Latino Eye Study," American Journal of Ophthalmology 139:1 (2005) p.30-38

Gaureault, J., et al., "Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration," Investigative Ophthalmology & Visual Science 46 (2005) p. 726-733

Gragoudas, E., et al., "Pegaptanib for neovascular age-related macular degeneration", American Journal of Ophthalmology 139:4 (2005) p.761-762

Grunwald, J., et al., "Reduced Foveolar Choroidal Blood Flow in Eyes with Increasing AMD Severity," Investigative Ophthalmology & Visual Science 46 (2005) p.1033-1038

Guymer, R., et al., "HMG CoA Reductase Inhibitors (Statins): Do They Have a Role in Age-related Macular Degeneration?," Survey of Ophthalmology 50:2 (2005) p.194-206

Hayashi, M., et al., "Gamma knife surgery for choroidal neovascularization in age-related macular degeneration. Technical note," Journal of Neurosurgery 102: Suppl (2005) p.200-3

Helbig, H., et al., "Simultaneous Fluorescein and Indocyanine Green Angiography for Exudative Macular Degeneration," Klinische Monatsblätter für Augenheilkunde. 222:3 (2005) p.202-5

Hera, R., et al., "Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration," American Journal of Ophthalmology 139:4 (2005) p. 589-596

Holcomb, C., and Lin, M., "Geographic variation in the prevalence of macular disease among elderly medicare beneficiaries in Kansas," American Journal of Public Health 95:1 (2005) p.75-77

Hossain, P., et al., "Artificial means for restoring vision," British Medical Journal 330:7481 (2005) p.30-3

Husain, D., et al., "Safety and Efficacy of Intravitreal Injection of Ranibizumab in Combination With Verteporfin PDT on Experimental Choroidal Neovascularization in the Monkey," Archives of Ophthalmology 123:4 (2005) p.509-516

Ikram, M., et al., "Retinal Vessel Diameters and the Risk of Incident Age-Related Macular Disease: The Rotterdam study," Ophthalmology 112:4 (2005) p.548-552

Jaakkola, A., et al., "Strontium Plaque Brachytherapy for Exudative Age-Related Macular Degeneration: Three-year results of a randomized study," Ophthalmology 112:4 (2005) p.567-573

Jahn, C. et al., "Macular pigment density in age-related maculopathy," Graefe's Archive for Clinical and Experimental Ophthalmology 243:3 (2005) p.228-234

Jiang, S., et al., "Oxidant-Induced Apoptosis in Human Retinal Pigment Epithelial Cells: Dependence on Extracellular Redox State," Investigative Ophthalmology & Visual Science 46 (2005) p.1054-1061

Johnson, E., et al., "Nutritional Manipulation of Primate Retinas, III: Effects of Lutein or Zeaxanthin Supplementation on Adipose Tissue and Retina of Xanthophyll-Free Monkeys," Investigative Ophthalmology & Visual Science 46 (2005) p.692-702

Johnson, E., et al., "Special Articles - Obesity, Lutein Metabolism, and Age-Related Macular Degeneration: A Web of Connections," Nutrition reviews. 63:1 (2005) p.9-15

Jonasson, F., et al., "5-year incidence of age-related maculopathy in the Reykjavik Eye Study," Ophthalmology 112:1 (2005) p.139-143

Karan, G., et al., "Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: A model for macular degeneration," Proceedings of the National Academy of Sciences of the United States of America. 102:11 (2005) p.4164-4169

King, R., et al., "Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition," Chemico-biological Interactions 151:1 (2005) p.143-149

Krummenauer, F., et al., "Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration," European Journal of Ophthalmology 15:1 (2005) p.74-80

MacLaren, R. and Aylward, G., "Delayed atrophy of the retinal pigment epithelium after submacular surgery," European Journal of Ophthalmology 15:1 (2005) p.170-172

McGwin, G., et al., "The use of cholesterol-lowering medications and age-related macular degeneration," Ophthalmology 112:3 (2005) p.488-494

Mainster, M., "Intraocular Lenses Should Block UV Radiation and Violet but Not Blue Light," Archives of Ophthalmology 123:4 (2005) p.550-555

Margrain, T.H., et al., "Do blue light filters confer protection against age-related macular degeneration?," American Journal of Ophthalmology 139:2 (2005) p.398.

Markomichelakis, N., et al., "Regression of neovascular age-related macular degeneration following infliximab therapy", American Journal of Ophthalmology 139:3 (2005) p.537-540

Meyer, C., et al., "Functional changes after photodynamic therapy with verteporfin," American Journal of Ophthalmology 139:1 (2005) p.214-215

Neelam, K., et al., "Measurement of Macular Pigment: Raman Spectroscopy versus Heterochromatic Flicker Photometry," Investigative Ophthalmology & Visual Science 46 (2005) p.1023-1032

Newsom, R., et al., "Results 28 Months Following Transpupillary Thermotherapy for Classic and Occult Choroidal Neovascularization in Patients With Age-Related Macular Degeneration," Ophthalmic Surgery, Lasers and Imaging 36:2 (2005) p.94-102

Nishiguchi, K., et al., "Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases,"
Human Mutation. 25:3 (2005) p.248-258

Perry, Patrick, "Breakthroughs in treating macular degeneration: once considered untreatable, age-related macular degeneration is yielding exciting "insights" into methods of prevention and promising new treatments," Saturday Evening Post (January-February 2005) - http://www.findarticles.com/p/articles/mi_m1189/is_1_277/ai_n8640761

Pirbhai, A., et al., "Prospective evaluation of digital non-stereo color fundus photography as a screening tool in age-related macular degeneration," neovascular age-related macular degeneration following infliximab therapy", American Journal of Ophthalmology 139:3 (2005) p.455-461

Remky, A. and Elsner, A. "Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease," British Journal of Ophthalmology 89:4 (2004) p.464-469

Remky, A., et al., "Topical dorzolamide increases pericentral visual function in age-related maculopathy: pilot study findings with short-wavelength automated perimetry," Acta Ophthalmologica Scandinavica 83:2 (2005) p. 154-160

Sahni, J. et al., "Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study," British Journal of Ophthalmology 89:3 (2005) p.316-320

Schachat, A., "New Treatments for Age-Related Macular Degeneration," Ophthalmology 112:4 (2005) p.531-532

Schein, O., et al., "Photodynamic Therapy With Verteporfin: Observations on the Introduction of a New Treatment Into Clinical Practice," Archives of Ophthalmology 123:1 (2005) p.58-63

Schneider, U. et al., "Natural course of occult choroidal neovascularization in age-related macular degeneration: development of classic lesions in fluorescein angiography," Acta Ophthalmologica Scandinavica 83:2 (2005) p.141-147

Schuele, G., et al., "RPE Damage Thresholds and Mechanisms for Laser Exposure in the Microsecond-to-Millisecond Time Regimen," Investigative Ophthalmology & Visual Science 46 (2005) p.714-719

Seddon, J., et al., "The US Twin Study of Age-Related Macular Degeneration: Relative Roles of Genetic and Environmental Influences," Archives of Ophthalmology 123:3 (2005) p.321-327

Sengupta, N., et al., "Preventing Stem Cell Incorporation into Choroidal Neovascularization by Targeting Homing and Attachment Factors," Investigative Ophthalmology & Visual Science 46 (2005) p.343-348

Smith, R., et al, "Role of Complement and Complement Membrane Attack Complex in Laser-Induced Choroidal Neovascularization," British Journal of Ophthalmology 89:1 (2005) p.87-91

Smith, R., et al., "Automated detection of macular drusen using geometric background leveling and threshold selection," Archives of Ophthalmology 123:2 (2005) p.200-206

Stepinac, T., et al., "Light-Induced Retinal Vascular Damage by Pd-porphyrin Luminescent Oxygen Probes," Investigative Ophthalmology & Visual Science 46 (2005) p.956-966

Thomas, R., et al., "Pseudoexfoliation in Southern India: The Andhra Pradesh Eye Disease Study," Investigative Ophthalmology & Visual Science 46 (2005) p.1170-1176

Umeda, S., et al., "Early-Onset Macular Degeneration with Drusen in a Cynomolgus Monkey (Macaca fascicularis) Pedigree: Exclusion of 13 Candidate Genes and Loci," Investigative Ophthalmology & Visual Science 46 (2005) p.683-691

Van Wijngaarden, P. et al., "Inhibitors of ocular neovascularization: promises and potential problems," JAMA : the journal of the American Medical Association 293:12 (2005) p.1509-1513

Weber, U. and Hecker, H., "Transpupillare Thermotherapie bei okkulten subretinalen Neovaskularisationen," Der Ophthalmologe 102:4 (2005) p.355-362

West, E., and Schein, O., "Sunlight and Age-Related Macular Degeneration," International Ophthalmology Clinics 45:1 (2005) p.41-47

Xue-Fang, W., et al., "Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells," Investigative Ophthalmology & Visual Science 46 (2005) p.1508-1515

Zawinka, C., et al, "Prevalence of Patients presenting with Neovascular Age-Related Macular Degeneration in an Urban Population," Retina 25:3 (2005) p.324-3321

Age-Related Eye Disease Study Research Group, "Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19," Ophthalmology 112:4 (2005) p.533-539

Preferential Hyperacuity Perimeter (PHP) Research Group, "Results of a Multicenter Clinical Trail to Evaluate the Preferentail Hyperacuity Perimeter for Detection of Age-Related Macular Degeneration," Retina 25:3 (2005) p.296-303

"Warding off macular degeneration. The case for vitamin and mineral supplements to fight AMD is getting stronger with each study; but so is the case for good nutrition," Health News 11:4 (2005) p.13-14